Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Acquired by CreativeOne Wealth LLC

CreativeOne Wealth LLC raised its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 32.6% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,320 shares of the medical instruments supplier’s stock after buying an additional 1,307 shares during the quarter. CreativeOne Wealth LLC’s holdings in Merit Medical Systems were worth $526,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Opal Wealth Advisors LLC bought a new stake in shares of Merit Medical Systems during the 2nd quarter valued at about $29,000. DekaBank Deutsche Girozentrale acquired a new position in Merit Medical Systems in the first quarter valued at approximately $44,000. USA Financial Formulas bought a new position in shares of Merit Medical Systems during the third quarter valued at approximately $59,000. GAMMA Investing LLC raised its position in shares of Merit Medical Systems by 142.3% during the 2nd quarter. GAMMA Investing LLC now owns 831 shares of the medical instruments supplier’s stock worth $71,000 after purchasing an additional 488 shares during the period. Finally, National Bank of Canada FI bought a new stake in shares of Merit Medical Systems in the 2nd quarter worth approximately $77,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Insider Activity at Merit Medical Systems

In other news, CFO Raul Jr. Parra sold 29,646 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $98.02, for a total transaction of $2,905,900.92. Following the completion of the sale, the chief financial officer now directly owns 16,361 shares of the company’s stock, valued at $1,603,705.22. This represents a 64.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director F. Ann Millner sold 12,500 shares of Merit Medical Systems stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $101.55, for a total value of $1,269,375.00. Following the completion of the transaction, the director now directly owns 32,391 shares in the company, valued at $3,289,306.05. This represents a 27.85 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 3.70% of the company’s stock.

Analyst Ratings Changes

MMSI has been the topic of several analyst reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $109.00 target price on shares of Merit Medical Systems in a research report on Thursday, October 31st. Barrington Research reiterated an “outperform” rating and issued a $114.00 price objective on shares of Merit Medical Systems in a research report on Thursday, October 31st. Robert W. Baird boosted their target price on shares of Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. Piper Sandler restated an “overweight” rating and issued a $110.00 price target (up previously from $100.00) on shares of Merit Medical Systems in a research note on Monday, September 9th. Finally, Bank of America boosted their price objective on Merit Medical Systems from $92.00 to $103.00 and gave the stock a “neutral” rating in a research report on Monday, September 16th. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $103.36.

Merit Medical Systems Stock Up 0.2 %

MMSI opened at $103.90 on Monday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.82 and a current ratio of 5.36. The company has a market capitalization of $6.06 billion, a PE ratio of 50.93, a P/E/G ratio of 2.58 and a beta of 0.89. The stock’s fifty day moving average is $99.06 and its 200-day moving average is $91.78. Merit Medical Systems, Inc. has a one year low of $65.46 and a one year high of $106.87.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Wednesday, October 30th. The medical instruments supplier reported $0.86 EPS for the quarter, topping the consensus estimate of $0.80 by $0.06. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. The firm had revenue of $339.85 million for the quarter, compared to analysts’ expectations of $334.60 million. During the same period in the previous year, the business earned $0.75 earnings per share. Merit Medical Systems’s revenue for the quarter was up 7.8% compared to the same quarter last year. On average, equities analysts predict that Merit Medical Systems, Inc. will post 3.36 EPS for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.